Terms: = Thyroid cancer AND PWWP2A, Q8IYR3_HUMAN, Q96N64, MST101, MGC132770, KIAA1935, ENSG00000170234, 114825 AND Prognosis
681 results:
1. VDR is a potential prognostic biomarker and positively correlated with immune infiltration: a comprehensive pan-cancer analysis with experimental verification.
Xia X; Xu F; Dai D; Xiong A; Sun R; Ling Y; Qiu L; Wang R; Ding Y; Lin M; Li H; Xie Z
Biosci Rep; 2024 May; 44(5):. PubMed ID: 38639057
[TBL] [Abstract] [Full Text] [Related]
2. DNA Methylation-Regulated HOXC8's Role in HER2-Positive Breast cancer Function and its Contribution to Herceptin Resistance.
Xie X; Tang S; Yu Z
Discov Med; 2024 Mar; 36(182):559-570. PubMed ID: 38531796
[TBL] [Abstract] [Full Text] [Related]
3. Osteopontin promotes tumor growth and metastasis and GPX4-mediated anti-lipid peroxidation in triple-negative breast cancer by activating the PI3k/Akt/mTOR pathway.
Guo M; Liu M; Li W; Wang C; Zhang L; Zhang H
J Cancer Res Clin Oncol; 2024 Mar; 150(3):155. PubMed ID: 38526702
[TBL] [Abstract] [Full Text] [Related]
4. GSG2 promotes thyroid cancer via stabilizing AURKB and activating AKT pathway.
Zhang F; Huang C
Aging (Albany NY); 2024 Mar; 16(6):5091-5107. PubMed ID: 38441546
[TBL] [Abstract] [Full Text] [Related]
5. Surrogate endpoints in clinical trials of p16-positive squamous cell carcinoma of the oropharynx: an individual patient data meta-analysis.
Gharzai LA; Morris E; Suresh K; Nguyen-Tân PF; Rosenthal DI; Gillison ML; Harari PM; Garden AS; Koyfman S; Caudell JJ; Jones CU; Mitchell DL; Krempl G; Ridge JA; Gensheimer MF; Bonner JA; Filion E; Dunlap NE; Stokes WA; Le QT; Torres-Saavedra P; Mierzwa M; Schipper MJ
Lancet Oncol; 2024 Mar; 25(3):366-375. PubMed ID: 38423050
[TBL] [Abstract] [Full Text] [Related]
6. [Clinical characteristics and prognostic factors of breast cancer patients with tumor deposits in the ipsilateral axillary region].
Xiao JJ; Huang ML; Yan CJ; Ling R; Wei HL
Zhonghua Zhong Liu Za Zhi; 2024 Feb; 46(2):146-154. PubMed ID: 38418189
[No Abstract] [Full Text] [Related]
7. miRNA-449c-5p regulates the JAK-STAT pathway in inhibiting cell proliferation and invasion in human breast cancer cells by targeting ERBB2.
Li L; Zhang Y; Yang K; Liu W; Zhou Z; Xu Y
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1974. PubMed ID: 38351535
[TBL] [Abstract] [Full Text] [Related]
8. [TRIP13 Enhances Radioresistance of Lung Adenocarcinoma Cells
through the Homologous Recombination Pathway].
Ge S; Gu R; Yang X; Xu C; Wang S; Zhu G
Zhongguo Fei Ai Za Zhi; 2024 Jan; 27(1):1-12. PubMed ID: 38296621
[TBL] [Abstract] [Full Text] [Related]
9. Systematic analysis of the role of LDHs subtype in pan-cancer demonstrates the importance of LDHD in the prognosis of hepatocellular carcinoma patients.
Wang S; Wu X; Wu X; Cheng J; Chen Q; Qi Z
BMC Cancer; 2024 Jan; 24(1):156. PubMed ID: 38291366
[TBL] [Abstract] [Full Text] [Related]
10. Bioinformatics analysis identifies coagulation factor II receptor as a potential biomarker in stomach adenocarcinoma.
Wu X; Wang S; Wang C; Wu C; Zhao Z
Sci Rep; 2024 Jan; 14(1):2468. PubMed ID: 38291086
[TBL] [Abstract] [Full Text] [Related]
11. Mini review of photoacoustic clinical imaging: a noninvasive tool for disease diagnosis and treatment evaluation.
Liu H; Wang M; Ji F; Jiang Y; Yang M
J Biomed Opt; 2024 Jan; 29(Suppl 1):S11522. PubMed ID: 38230369
[TBL] [Abstract] [Full Text] [Related]
12. Novel quantitative immunohistochemistry method using histone H3, family 3B as the internal reference standard for measuring human epidermal growth factor receptor 2 expression in breast cancer.
Wang J; Xia YC; Tian BX; Li JT; Li HY; Dong H; Li XG; Yu H; Zhu YY; Ma J; Jiang YJ; Jin GZ
Cancer; 2024 Apr; 130(S8):1424-1434. PubMed ID: 38217532
[TBL] [Abstract] [Full Text] [Related]
13. Integration of scRNA and bulk RNA-sequence to construct the 5-gene molecular prognostic model based on the heterogeneity of thyroid carcinoma endothelial cell.
Ni Z; Cong S; Li H; Liu J; Zhang Q; Wei C; Pan G; He H; Liu W; Mao A
Acta Biochim Biophys Sin (Shanghai); 2024 Feb; 56(2):255-269. PubMed ID: 38186223
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic significance and immunological role of HPRT1 in human cancers.
Lu Y; Chen R; Zhang H; Sun X; Li X; Yang M; Zhang X
Biomol Biomed; 2024 Mar; 24(2):262-291. PubMed ID: 38159260
[TBL] [Abstract] [Full Text] [Related]
15. Construction of a ferroptosis-based prognostic model for breast cancer helps to discriminate high/low risk groups and treatment priority.
Zhang L; Zhao T; Wu X; Tian H; Gao P; Chen Q; Chen C; Zhang Y; Wang S; Qi X; Sun N
Front Immunol; 2023; 14():1264206. PubMed ID: 38152394
[TBL] [Abstract] [Full Text] [Related]
16. TMX family genes and their association with prognosis, immune infiltration, and chemotherapy in human pan-cancer.
Luo N; Mei Z; Zhang Q; Tang H; Wan R; Deng A; Zou X; Lv C
Aging (Albany NY); 2023 Dec; 15(24):15064-15083. PubMed ID: 38147024
[TBL] [Abstract] [Full Text] [Related]
17. SLC35A2 expression drives breast cancer progression via ERK pathway activation.
Yang X; Tao Y; Xu Y; Cai W; Shao Q
FEBS J; 2024 Apr; 291(7):1483-1505. PubMed ID: 38143314
[TBL] [Abstract] [Full Text] [Related]
18. Notch3 restricts metastasis of breast cancers through regulation of the JAK/STAT5A signaling pathway.
Chen MN; Fang ZX; Wu Z; Bai JW; Li RH; Wen XF; Zhang GJ; Liu J
BMC Cancer; 2023 Dec; 23(1):1257. PubMed ID: 38124049
[TBL] [Abstract] [Full Text] [Related]
19. Association of
Trivedi V; Noronha V; Sreekanthreddy P; Desai S; Poojary D; Varghese L; Gowda P; Butle A; Mishra R; Bal M; Mittal N; Rane S; Kane S; Basu S; Patil V; Menon N; Singh AK; Chaturvedi P; Chandrani P; Choughule A; Veldore V; Prabhash K; Dutt A
Front Endocrinol (Lausanne); 2023; 14():1152514. PubMed ID: 38027096
[TBL] [Abstract] [Full Text] [Related]
20. Incidence and mortality of second primary malignancies after lymphoma: a population-based analysis.
Liu Y; Chu Y; Liu J; Ge X; Ding M; Li P; Liu F; Zhou X; Wang X
Ann Med; 2023; 55(2):2282652. PubMed ID: 38010751
[TBL] [Abstract] [Full Text] [Related]
[Next]